GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 38 filers reported holding GALERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140 | -99.3% | 800 | -86.9% | 0.00% | – |
| Q2 2023 | $19,057 | +331.1% | 6,108 | +253.7% | 0.00% | – |
| Q1 2023 | $4,421 | +208.9% | 1,727 | +79.9% | 0.00% | – |
| Q4 2022 | $1,431 | -28.4% | 960 | +6.7% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 900 | -69.2% | 0.00% | – |
| Q2 2022 | $3,000 | -75.0% | 2,919 | -39.5% | 0.00% | – |
| Q1 2022 | $12,000 | -82.1% | 4,826 | -66.8% | 0.00% | – |
| Q4 2021 | $67,000 | -56.5% | 14,544 | -23.1% | 0.00% | – |
| Q3 2021 | $154,000 | -37.7% | 18,923 | -24.7% | 0.00% | – |
| Q2 2021 | $247,000 | +22.3% | 25,144 | +9.7% | 0.00% | – |
| Q1 2021 | $202,000 | -30.6% | 22,925 | -19.3% | 0.00% | – |
| Q4 2020 | $291,000 | +142.5% | 28,417 | +114.2% | 0.00% | – |
| Q3 2020 | $120,000 | +73.9% | 13,267 | +36.3% | 0.00% | – |
| Q2 2020 | $69,000 | +122.6% | 9,737 | +206.0% | 0.00% | – |
| Q1 2020 | $31,000 | +93.8% | 3,182 | +163.2% | 0.00% | – |
| Q4 2019 | $16,000 | – | 1,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
| Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
| Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
| ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
| Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
| Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
| XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
| Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
| Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
| Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |